Due to COVID-19, new study enrollment is being assessed on a case by case basis. If you have any questions please call our central phone number at 616-391-1230.

Print

Cancer Research Consortium of West Michigan

All Open Clinical Trials

Provided drugs are underlined

For more information, call the CRCWM Main office at 616.391.1230 or 800.336.5079

Brain/CNS

Craniopharyngioma

Low and Intermediate Grade (Grade II and III) Glioma

Meningioma

Metastases to Brain

Cancer Control

Pediatric

Breast

Post-Neoadjuvant

Adjuvant

Metastatic

Biospecimen

Cancer Control

Screening

Cancer Care Delivery (CCDR)

Gastrointestinal

Genitourinary

Hematologic

Pediatric

Cancer Control

Biospecimen

Brain

Breast

Head and Neck

Gastrointestinal

Genitourinary

Lung

Multisite

Screening

Pediatric

Gastrointestinal

Adenocarcinoma of the Colon

Colorectal Cancer

Anal Cancer

Billiary Tract Cancers

Gastroenteropancreatic Neuroendocrine Tumors (GEP NETs)

Biospecimen

Cancer Control

CCDR

Screening

Pediatric

Genitourinary

Prostate Cancer

Renal Cell Carcinoma

Urothelial Tract/Bladder Cancer

Germ Cell Cancer

Biospecimen

Cancer Control

CCDR

Pediatric

Germ Cell

Pediatric

Gynecologic

Ovarian Cancer

Cervical Cancer (sq, adeno, adeno sq)

Uterine Cancer

Biospecimen

Cancer Control

Head and Neck

Head and Neck Squamous Cell Carcinoma, NOS

Biospecimen

Cancer Control

Leukemia

Acute Lymphoblastic Leukemia (ALL)

Acute Myeloid Leukemia (AML)

Chronic Lymphocytic Leukemia (CLL)

Chronic Myelogenous Leukemia (CML)

Biospecimen

CCDR

Pediatric

Lung

Non-Small Cell Lung Cancer

Small Cell Lung Cancer

Biospecimen

Cancer Control

Screening

Lymphoma

Diffuse Large B-Cell Lymphoma

Follicular Lymphoma

Mantle Cell Lymphoma

Classical Hodgkin Lymphoma

Pediatric

Melanoma

Melanoma

Squamous Cell Carcinoma of the Skin

Biospecimen

Multisite

Other

Treatment

Biospecimen

Cancer Control

CCDR

Screening

Pediatric

Closed

Myeloma

Daratumumab/rHuPH20+/- Lenalidomide as Post-ASCT Maintenance for MM w/MRD to Direct Therapy Duration

Relapsed Disease, and Subsequently Progressed on Lenalidomide (Lenalidomide-Refractory Disease)

CCDR

Neuroblastoma

Pediatric

Rare

Breast

Gastrointestinal

Genitourinary

Head and Neck

Lung

Lymphoma

Melanoma

Multisite

Myeloma

Sarcoma

Pediatric

Cancer clinical trials are research studies for developing better ways of detecting, treating, and eventually preventing cancer. By taking part in a clinical trial, you are among the first to receive new research treatments before they are widely available. Your participation in a clinical trial will influence the future direction of cancer care.

If you are interested in participating in a clinical trial, consult with your physician. Please note: clinical trials are not risk free. Patients must explore the options that are best for their individuals needs with the help of their physician.